Close

Analyst Ratings for Emergent BioSolutions (EBS)

EBS Rating Summary

EBS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on EBS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.50 (+244.1%) * Over Last 12-Mos
Rating Score: 6.3 / 10   Percentile Rank: 67%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/7/2024 Benchmark Robert Wasserman Upgrade Buy
(Hold)
5.00
(N/A)
3.26
(2.47)
-24.23% Details
11/20/2023 JPMorgan Jessica Fye New Coverage Underweight
(N/A)
N/A
(N/A)
2.12
(2.47)
16.51% Details
Like EBS Ratings? Also take a look at KVUE, JNJ, AAP, SPGI

EBS Ratings News